Study of XL647 in Subjects With Non-Small-Cell Lung Cancer
Condition(s):Non-small-cell Lung CancerLast Updated:May 13, 2022Completed
Hide Studies Not Open or Pending
Condition(s):Non-small-cell Lung CancerLast Updated:May 13, 2022Completed
Condition(s):CancerLast Updated:May 13, 2022Completed
Condition(s):Carcinoma, Non-Small-Cell LungLast Updated:May 13, 2022Completed
Condition(s):CancerLast Updated:May 13, 2022Completed
Condition(s):Cancer; Non-small-cell Lung Cancer; Breast CancerLast Updated:August 20, 2015Withdrawn
Condition(s):Polycystic Kidney, Autosomal DominantLast Updated:May 31, 2022Completed
Condition(s):Glioblastoma; Recurrent Glioblastoma; Brain TumorLast Updated:September 22, 2021Completed
Condition(s):Non-Small Cell Lung Cancer; Leptomeningeal Metastases; Brain MetastasesLast Updated:March 16, 2022Completed
Condition(s):Autosomal Dominant Polycystic Kidney Disease (ADPKD)Last Updated:May 25, 2022Terminated
Condition(s):HER-2 Positive Breast Cancer; Metastatic Malignant Neoplasm to BrainLast Updated:April 27, 2022Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.